Valneva (VALN)
(Delayed Data from NSDQ)
$7.76 USD
+0.11 (1.44%)
Updated Aug 23, 2024 11:05 AM ET
After-Market: $7.68 -0.08 (-1.03%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
VALN 7.76 +0.11(1.44%)
Will VALN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VALN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VALN
How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3%
Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect?
VALN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
Strength Seen in Valneva SE Sponsored ADR (VALN): Can Its 15.8% Jump Turn into More Strength?
Other News for VALN
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
Kepler Capital Keeps Their Buy Rating on Valneva (0OB3)
Buy Rating on Valneva Amid Strong Q2 Performance and Promising Lyme Vaccine Outlook
Analyst Scoreboard: 8 Ratings For Valneva